Literature DB >> 18288882

AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect.

F Jon Geske1, Kirk E Guyer, Gordon Ens.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18288882     DOI： 10.1007/BF03256268

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


× No keyword cloud information.
  9 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?

Authors:  Leszek Markuszewski; Marcin Rosiak; Jacek Golanski; Jacek Rysz; Magdalena Spychalska; Cezary Watala
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-05       Impact factor: 4.080

3.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

4.  The global burden of disease, 1990-2020.

Authors:  A D Lopez; C C Murray
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 5.  Narrative review: aspirin resistance and its clinical implications.

Authors:  Simon Sanderson; Jon Emery; Trevor Baglin; Ann-Louise Kinmonth
Journal:  Ann Intern Med       Date:  2005-03-01       Impact factor: 25.391

6.  Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.

Authors:  Nauder Faraday; Diane M Becker; Lisa R Yanek; Jesus Enrique Herrera-Galeano; Jodi B Segal; Taryn F Moy; Paul F Bray; Lewis C Becker
Journal:  Am J Cardiol       Date:  2006-07-28       Impact factor: 2.778

7.  Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Authors:  John W Eikelboom; Jack Hirsh; Jeffrey I Weitz; Marilyn Johnston; Qilong Yi; Salim Yusuf
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

8.  Experiences with aspirin (Acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis.

Authors:  L L CRAVEN
Journal:  Miss Valley Med J       Date:  1953-01

Review 9.  Aspirin resistance.

Authors:  Graeme J Hankey; John W Eikelboom
Journal:  Lancet       Date:  2006-02-18       Impact factor: 79.321
  9 in total
  3 in total

1.  Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.

Authors:  M T Olson; T S Kickler; J A Lawson; R C McLean; J Jani; G A FitzGerald; J J Rade
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

Review 2.  Plateletworks: a novel point of care platelet function screen.

Authors:  James Campbell; Helen Ridgway; David Carville
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Aspirin prophylaxis for the prevention of thrombosis: expectations and limitations.

Authors:  Gundu H R Rao; Jawad Fareed
Journal:  Thrombosis       Date:  2012-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.